Lovastatin Increases Surface Low Density Lipoprotein Receptor Expression by Retarding the Receptor Internalization Rate in Proliferating Lymphocytes
- 1 June 1997
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 235 (1) , 117-122
- https://doi.org/10.1006/bbrc.1997.6736
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Inhibitors of Cholesterol Biosynthesis Increase Hepatic Low-Density Lipoprotein Receptor Protein DegradationArchives of Biochemistry and Biophysics, 1996
- Enhanced cellular metabolism of very low density lipoprotein by simvastatin. A novel mechanism of action of HMG‐CoA reductase inhibitorsEuropean Journal of Clinical Investigation, 1994
- HMG-CoA Reductase Inhibitors for Treatment of HypercholesterolemiaNew England Journal of Medicine, 1988
- Mevinolin, an inhibitor of cholesterol synthesis, induces mRNA for low density lipoprotein receptor in livers of hamsters and rabbits.Proceedings of the National Academy of Sciences, 1986
- Hypocholesterolemic effects of mevinolin in patients with heterozygous familial hypercholesterolemia.Journal of Clinical Investigation, 1984
- Mevinolin and colestipol stimulate receptor-mediated clearance of low density lipoprotein from plasma in familial hypercholesterolemia heterozygotes.Proceedings of the National Academy of Sciences, 1983
- Cholesterol-lowering effect of mevinolin, an inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme a reductase, in healthy volunteers.Journal of Clinical Investigation, 1982
- Regulatory role for hepatic low density lipoprotein receptors in vivo in the dog.Proceedings of the National Academy of Sciences, 1981
- Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent.Proceedings of the National Academy of Sciences, 1980
- Regulation of HMG-CoA ReductasePublished by Elsevier ,1976